- Home
- ABOS vs MASS Comparison
ABOS vs MASS Comparison
Compare ABOS & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- MASS
- Stock Information
- Founded
- ABOS 1996
- MASS 2012
- Country
- ABOS United States
- MASS United States
- Employees
- ABOS N/A
- MASS N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- ABOS Health Care
- MASS Health Care
- Exchange
- ABOS Nasdaq
- MASS Nasdaq
- Market Cap
- ABOS 66.6M
- MASS 84.3M
- IPO Year
- ABOS 2021
- MASS 2020
- Fundamental
- Price
- ABOS $1.00
- MASS $5.79
- Analyst Decision
- ABOS Strong Buy
- MASS Buy
- Analyst Count
- ABOS 3
- MASS 3
- Target Price
- ABOS $7.33
- MASS $5.33
- AVG Volume (30 Days)
- ABOS 213.2K
- MASS 456.1K
- Earning Date
- ABOS 05-13-2025
- MASS 05-13-2025
- Dividend Yield
- ABOS N/A
- MASS N/A
- EPS Growth
- ABOS N/A
- MASS N/A
- EPS
- ABOS N/A
- MASS N/A
- Revenue
- ABOS N/A
- MASS $59,631,000.00
- Revenue This Year
- ABOS N/A
- MASS N/A
- Revenue Next Year
- ABOS N/A
- MASS $18.84
- P/E Ratio
- ABOS N/A
- MASS N/A
- Revenue Growth
- ABOS N/A
- MASS 18.72
- 52 Week Low
- ABOS $0.86
- MASS $1.81
- 52 Week High
- ABOS $3.92
- MASS $7.48
- Technical
- Relative Strength Index (RSI)
- ABOS 44.19
- MASS 66.62
- Support Level
- ABOS $1.00
- MASS $5.01
- Resistance Level
- ABOS $1.13
- MASS $5.73
- Average True Range (ATR)
- ABOS 0.10
- MASS 0.41
- MACD
- ABOS 0.00
- MASS -0.00
- Stochastic Oscillator
- ABOS 48.33
- MASS 89.58
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.